Johnson, Darryl N.
Ruan, Zheng
Petley, Emma V.
Devi, Sapna
Holz, Lauren E.
Uldrich, Adam P.
Mak, Jeffrey Y. W.
Hor, Jyh Liang
Mueller, Scott N.
McCluskey, James
Fairlie, David P.
Darcy, Phillip K.
Beavis, Paul A.
Heath, William R.
Godfrey, Dale I.
Funding for this research was provided by:
Australian Research Council Center of Excellence in Advanced Molecular Imaging (CE140100011)
National Health and Medical Research Council (1113293, APP1125493, 1136680)
Article History
Received: 25 July 2021
Accepted: 17 January 2022
First Online: 8 March 2022
Competing interests
: JYWM, DPF and JMc are inventors on patents describing MR1 tetramers and MR1 ligands. DIG and WRH are members of the scientific advisory board for Avalia Immunotherapies, a company that is developing NKT cell-based vaccines. DIG and WRH are also inventors on a patent describing the use of CD1-lipid-Ag-containing malaria vaccines. All other authors have no conflicts of interest to declare.